Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2010
11/24/2010CN101890077A Preparation method and quality detection method of rhizoma corydalis pain relieving soft capsules
11/24/2010CN101890072A Skelalgia powder for treating cold dampness leg
11/24/2010CN101890067A Anti-inflammatory and analgesic snow lotus gel and preparation method thereof
11/24/2010CN101890058A Health-care bio-chip based on nano-taxus and preparation method thereof
11/24/2010CN101890049A Pediatric paracetamol oral solution formula and preparation method thereof
11/24/2010CN101890033A Application of paederosidic acid used for preparing analgesic drugs and/or anti-inflammatory drugs
11/24/2010CN101890012A Paracetamol,loratadine and pseudoephedrine sulfate sustained release tablet and preparation method thereof
11/24/2010CN101889997A Ibuprofen-containing medicinal composition for injection
11/24/2010CN101889985A Medicament-carrying nano microspheres and preparation method thereof
11/24/2010CN101889953A Device and method for manufacturing drug smoke liquid and drug smoke
11/24/2010CN101889946A Smokeless black bean moxibustion instrument
11/24/2010CN101380302B Potasium dehydroandrographolide succinate injection and production method thereof
11/24/2010CN101229334B Medicine for treating rheumatoid and atrophic arthritis
11/24/2010CN101229244B Adjuvant therapy rheumatoid arthritis external medicine and preparing method thereof
11/24/2010CN101181305B Extract of acaleph toxin as well as preparation method and usage thereof
11/24/2010CN101175722B Azetidine derivatives as ccr-3 receptor antagonists
11/24/2010CN101160311B Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid
11/24/2010CN101139393B KDR peptides and vaccines containing the same
11/24/2010CN101129971B Traditional Chinese medicine composition for treating women's menorrhalgia and menoxenia, and method of preparing the same
11/24/2010CN101095729B Medicine for treating lumbar intervertebral disc protrusion
11/23/2010US7838635 CD16A binding proteins and use for the treatment of immune disorders
11/23/2010US7838555 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
11/23/2010US7838541 Methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.
11/23/2010US7838540 3-aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as p38 kinase inhibitors
11/23/2010US7838506 nonpeptidic inhibitors of cathepsin G; genetic diseases, degenerative diseases, DNA damages, neoplasia and/or skin diseases; DNA or polynucleotide sequences having a chain length of at least 60 nucleotides and being substantially not subjected to undergo efficient base pairing
11/23/2010US7836883 Methods for treating rhinitis and conjunctivitis
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/23/2010CA2438870C Novel inhibitors of formation of advanced glycation endproducts (ages)
11/23/2010CA2377309C Compounds for the modulation of ppar.gamma. activity
11/23/2010CA2223989C Prodrugs of pharmaceuticals with improved bioavailability
11/23/2010CA2194501C Method of regulating immune function
11/18/2010WO2010132599A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/18/2010WO2010132525A1 Compounds containing acyclic n-o bonds for phototherapy
11/18/2010WO2010132247A1 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010WO2010132016A1 Bis-(sulfonylamino) derivatives for treatment of pain and inflammation
11/18/2010WO2010131909A2 Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
11/18/2010WO2010131738A1 Azetidine compound and medicinal use thereof
11/18/2010WO2010131703A1 NOVEL PPARγ PROMOTER SEQUENCE AND USE APPLICATION THEREOF
11/18/2010WO2010131116A2 Use of lipid conjugates in the treatment of diseases associated with vasculature
11/18/2010WO2010130945A1 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130944A1 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130943A1 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130934A2 2-cycloamino-5-(pyridin-4-yl)imidazo[2,1-b][1,3,4]thiadiazole derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130799A2 Method for impregnation with supercritical co2
11/18/2010WO2010130702A1 Infant and young children feeding formula comprising probiotics for infants and young children
11/18/2010WO2010130659A1 Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
11/18/2010WO2010130224A1 Thiophene derivatives
11/18/2010WO2010130178A1 Acrylamide derivative and use thereof in manufacture of medicament
11/18/2010WO2010130139A1 Ascorbic acid aryl acetate/propionate ester, preparation method and pharmaceutical composition thereof
11/18/2010WO2010111626A3 Poly (adp-ribose) polymerase (parp) inhibitors
11/18/2010WO2010103297A3 Bis aromatic compounds for use as ltc4 synthase inhibitors
11/18/2010WO2010102154A3 Biaryl oxyacetic acid compounds
11/18/2010WO2010101627A3 Methods and systems for treatment and/or diagnosis
11/18/2010WO2010078466A3 Sand fly salivary proteins with anti-complement activity and methods of their use
11/18/2010WO2010075423A3 Dendrimer based modular platforms
11/18/2010WO2010069605A3 Oxidized cardiolipin as a novel pro-inflammatory factor
11/18/2010WO2010042649A3 PHTHALAZINE COMPOUNDS AS p38 MAP KINASE MODULATORS AND METHODS OF USE THEREOF
11/18/2010WO2010039186A3 Benzoxazoles useful as faah modulators and uses thereof
11/18/2010WO2010033543A3 Substituted benzamides as cannabinoid receptor ligands
11/18/2010WO2009124733A8 Substituted sulfonamide derivatives
11/18/2010US20100292791 Fully synthetic implantable multi-phased scaffold
11/18/2010US20100292345 Therapeutic uses of cannabigerol
11/18/2010US20100292342 Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof
11/18/2010US20100292334 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
11/18/2010US20100292329 4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain
11/18/2010US20100292325 P-menthawe-3-carboxylic acid esters to treat airways diseases
11/18/2010US20100292298 Method and reagents for treating hepatic fibrosis and inflammation
11/18/2010US20100292296 Novel ligands that modulate rar receptors
11/18/2010US20100292295 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators
11/18/2010US20100292288 Crystalline forms of (r)-1-{2-[4`- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto
11/18/2010US20100292283 Novel phenyl-acetamide and phenyl-propionamide derivatives useful as potassium channel modulators
11/18/2010US20100292280 Anti-pyretic vasodilators
11/18/2010US20100292279 Bis-(Sulfonylamino) Derivatives in Therapy
11/18/2010US20100292276 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010US20100292268 Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use
11/18/2010US20100292266 Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase
11/18/2010US20100292254 Fused Pyrimidine Derivatives as Trpv3 Modulators
11/18/2010US20100292252 Vinyl-aryl derivatives for inflammation and immune-related uses
11/18/2010US20100292244 Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
11/18/2010US20100292235 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
11/18/2010US20100292233 Dihydro-1h-pyrrolo[1,2-a]indol-1-yl carboxylic acid derivatives which act as s1p1 agonists
11/18/2010US20100292231 Indazole Compounds for Treating Inflammatory Disorders, Demyelinating Disorders and Cancers
11/18/2010US20100292224 Isothiazolidine 1,1-dioxide and tetrahydro-2h-1,2-thiazine 1,1-dioxide derivatives as p2x7 modulators
11/18/2010US20100292213 Anti-Inflammatory Agents
11/18/2010US20100292207 Substituted indazole derivatives active as kinase inhibitors
11/18/2010US20100292205 Pyrimidone Compounds As GSK-3 Inhibitors
11/18/2010US20100292204 Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists
11/18/2010US20100292195 Low burst polymers and methods to produce polymer
11/18/2010US20100292190 Novel tubulin polymerisation inhibitors
11/18/2010US20100292188 Compounds Comprising A Cyclobutoxy Group
11/18/2010US20100292182 Cystitis treatment with high dose chondroitin sulfate
11/18/2010US20100292159 Method of treatment or prophylaxis of inflammatory pain
11/18/2010US20100292158 Compositions and Methods for Enhanced Pharmacological Activity of Compositions Comprising Peptide Drug Substances
11/18/2010US20100292153 Use of muramyl dipeptide (mdp) for treating inflammation
11/18/2010US20100292151 Use of human cytokine receptor
11/18/2010US20100291628 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost
11/18/2010US20100291235 Composition for treating sterile inflammation
11/18/2010US20100291234 Compositions and methods for treating inflammatory arthritis
11/18/2010US20100291228 Scavenger of in vivo harmful reactive oxygen species and/or free radicals
11/18/2010US20100291212 Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
1 ... 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 ... 1272